I just received this from my friend Missy, and I think it's worth sharing!
Many of you know that Sequenom had been developing a new test that they claimed could diagnose a first-trimester unborn baby with Down syndrome with up to 95% accuracy. It was a blood test, so it surely would be used often by women, and the likelihood that abortion rates for babies with DS would increase was a very real concern. The news came out today that the test release is delayed due to “the discovery by company officials of employee mishandling of R&D test data and results.”
I don't know what that means exactly, but I know that I'm pleased. Prenatal testing is a hot issue, and I'm not trying to debate that at this point. Just sharing the latest info on something that many of us have been watching.
Here's Patricia Bauer's article.
A brand new adventure...
-
I've learned to live one day at a time. Not because tomorrow's something
to be feared or not to be planned for, but because if you cannot enjoy
TODAY, th...
4 hours ago





2 comments:
I'm with you! Hopefully it will be delayed...FOREVER!
Having worked in R&D (not for anything like this), what it means is that either an employee falsified data (so that 95% accuracy can be a crap statistic) or paperwork was mishandled. In R&D, it's so important for every piece of data to be traceable via paperwork. If Sequenom was ever sued, by a parent or a competitor, and the paperwork was mishandled or missing, they would pretty much lose their suit.
They are covering their behinds on this.
Post a Comment